AMY FIDE: Open Payments
NPI 1891330999 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,494 in 43 payments from 9 companies in 2025. Trend: 2023 $387 · 2024 $1,123 · 2025 $1,494
Food & beverage: $1,494
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 14 | $368 |
| AstraZeneca Pharmaceuticals LP | 3 | $343 |
| Axsome Therapeutics, Inc. | 10 | $249 |
| Novo Nordisk Inc | 9 | $208 |
| Amgen Inc. | 1 | $125 |
| PFIZER INC. | 1 | $114 |
| Phathom Pharmaceuticals, Inc. | 3 | $45 |
| Hologic Sales and Service, LLC | 1 | $21 |
| Dexcom, Inc. | 1 | $21 |
Products named: AIRSUPRA, Ozempic, MOUNJARO, Auvelity, Repatha, BREZTRI, ZAVZPRET, Symbravo.
Industry payments across CA — which companies pay providers there.
